Default company panoramic image
Logo

zarzatech.com

Zarzatech is a specialized pharmaceutical company focus on the development of Periodontal products. R&D in the US and Europe.

  • Stage Full Product Ready
  • Industry Nanotechnology
  • Location United States
  • Currency USD
  • Founded April 2010
  • Website zarzatech.net

Company Summary

Zarzatech is focused on the prevention and treatment of Oral inflammatory diseases, unmet need in 80% of the population. Zarzatech is focused on the development of a platform medical device products, non-invasive with a triple action at the Oral mucosa barrier, preventing the progression of Gingivitis and periodontitis. Efficacy proven and studied in humans up to phase II trials.Experts in strategies bringing a product to the market in one year

Team

  • Default avatar
    Sonia Divney DDS, MSc, CAGS
    Founder CEO & President

    25 Years experience in dentistry and dental industry

  • Default avatar
    Massimo Radaelli PhD MBA
    Chairman

    25 Years experience in the pharmaceutical Industry bringing orphan disease drugs and oral health products to the market.

  • Default avatar
    Robert Singer
    CSO. Inventor.

    30 Years experience as a CSO bringing oral health products to the market.

  • Default avatar
    Bill Mackin
    Business Development and Regulatory

    25 years experience in the pharmaceutical Industry

Advisors

  • Default avatar
    Jeffrey Quillen
    Lawyer
    Unconfirmed
    Default avatar
    David Fogel
    Accountant
    Unconfirmed